Latest News

September 17, 2014

Debiopharm Diagnostics portfolio company Biocartis ships its first Idylla instrument

March 5, 2014

Immunexpress Closes USD 6 Million Financing Round led by Debiopharm Group™

January 8, 2014

Spinomix announces a milestone payment from Debiopharm Group™ and the appointment of a new CEO

June 7, 2013

Diagnoplex S.A. closes a financing round led by Debiopharm Group™

January 9, 2013

Spinomix closes a $ 3 Million financing round led by Debiopharm Group™

June 19, 2012

Debiopharm, Immunexpress and Biocartis Announce Collaboration to Advance Development of SeptiCyte® Triage for Managing Sepsis

April 8, 2010

Debiopharm Group™ and Biocartis embark on a partnership aiming at enhancing personalized medicine

June 27, 2005

Debiopharm and Neovacs sign License and Equity Agreement for the development fo Neovacs´ anti-TNF-Alpha product